Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma
Veronica Veschi(National Cancer Institute), Zhihui Liu(National Cancer Institute), Ty C. Voss(National Cancer Institute), Laurent Ozbun(National Cancer Institute), Berkley E. Gryder(National Cancer Institute), Chunhua Yan(National Cancer Institute), Ying Hu(National Cancer Institute), Anqi Ma(Icahn School of Medicine at Mount Sinai), Jian Jin(Icahn School of Medicine at Mount Sinai), Sharlyn J. Mazur(National Cancer Institute), Norris Lam(National Cancer Institute), Bárbara Kunzler Souza(National Cancer Institute), Giuseppe Giannini(Istituto Pasteur), Gordon L. Hager(National Institutes of Health), C.H. Arrowsmith(University of Toronto), Javed Khan(National Cancer Institute), Ettore Appella(National Cancer Institute), Carol J. Thiele(National Cancer Institute)
Cited by 128Open Access